FDA Inspection
Abbvie Biotechnology Ltd.Abbvie Biotechnology Ltd. – FDA Inspection, Jun 10, 2026
Record Details
This FDA Inspection record concerns Abbvie Biotechnology Ltd., with an inspection on June 10, 2026, issued by the San Juan District Office, covering human drugs.
View Company Profile
ID · 5171fca6-80bf-44ca-b188-290a1bc76d8e
Inspection Facts
- Inspection number
- 1321476
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.100(b)SOPs not followed / documented
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.194(a)Complete test data included in records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Abbvie Biotechnology Ltd.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| October 30, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 13, 2017 | Not classified | San Juan District Office |
Other documents for Abbvie Biotechnology Ltd.
- FDA Inspection 1222107 - 2023-10-30
- FDA Inspection 1084057 - 2019-03-25
- FDA Inspection 1055102 - 2018-06-01
- FDA Inspection 1012249 - 2017-04-28
- FDA Inspection 1001477 - 2017-01-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.